UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women

Climacteric : the journal of the International Menopause Society, 2023-02, Vol.26 (1), p.55-63

2023

Volltextzugriff (PDF)

Low thrombin generation in postmenopausal women using estetrol

Climacteric : the journal of the International Menopause Society, 2024-04, Vol.27 (2), p.193-201

2024

Volltextzugriff (PDF)

Effect of different contraceptive methods on the oxidative stress status in women aged 40–48 years from the ELAN study in the province of Liège, Belgium

Human reproduction (Oxford), 2007-08, Vol.22 (8), p.2335-2343

2007

Volltextzugriff (PDF)

Exploring the Interest in and the Usage of the Internet Among Patients Eligible for Osteoporosis Screening

Calcified tissue international, 2015-06, Vol.96 (6), p.518-526

2015

Volltextzugriff (PDF)

Breast cancer and serum organochlorine residues

Occupational and environmental medicine (London, England), 2003-05, Vol.60 (5), p.348-351

2003

Volltextzugriff (PDF)

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

Contraception (Stoneham), 2003-06, Vol.67 (6), p.423-429

2003

Volltextzugriff (PDF)

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

Contraception (Stoneham), 2003-03, Vol.67 (3), p.173-185

2003

Volltextzugriff (PDF)

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

Contraception (Stoneham), 2004-04, Vol.69 (4), p.271-278

2004

Volltextzugriff (PDF)

(068) Low Drug-Drug interaction risk of Estetrol (E4), a Promising New Estrogen for the Treatment of Menopausal Symptoms

Journal of sexual medicine, 2023-05, Vol.20 (Supplement_2)

2023

Volltextzugriff (PDF)

ESTETROL/DROSPIRENONE SAFETY IN A CARDIOVASCULAR RISK POPULATION

Contraception (Stoneham), 2024-11, Vol.139, p.110650, Article 110650

2024

Volltextzugriff (PDF)

Skin climacteric aging and hormone replacement therapy

Journal of cosmetic dermatology, 2006-03, Vol.5 (1), p.3-8

2006

Volltextzugriff (PDF)

OC 35.3 Correlation between ETP-Based APC Resistance and the Relative Risk of Venous Thromboembolism in Women Using Combined Oral Contraceptives

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100665, Article 100665

2023

Volltextzugriff (PDF)

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

The lancet oncology, 2009-02, Vol.10 (2), p.135-146

2009

Volltextzugriff (PDF)

The benefits of estetrol addition to drospirenone for contraception

AJOG global reports, 2023-11, Vol.3 (4), p.100266-100266, Article 100266

2023

Volltextzugriff (PDF)

Relationship between bone mass density and tensile strength of the skin in women

European journal of clinical investigation, 2001-08, Vol.31 (8), p.731-735

2001

Volltextzugriff (PDF)

Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects

Maturitas, 1995-04, Vol.21 (3), p.171-178

1995

Volltextzugriff (PDF)

Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data

Journal de gynécologie, obstétrique et biologie de la reproduction, 2008-06, Vol.37 (4), p.340-345

Gaspard, U

2008

Volltextzugriff (PDF)

Prévention des troubles coronaires par le traitement hormonal précoce à la ménopause : une idée qui s’impose à nouveau

Journal de gynécologie, obstétrique et biologie de la reproduction, 2008-06, Vol.37 (4), p.340-345

Gaspard, U.

2008

Volltextzugriff (PDF)

Risks, benefits and costs of hormone replacement therapy in menopause

Revue médicale de Liège, 1998-05, Vol.53 (5), p.298

Gaspard, U

1998

Volltextzugriff (PDF)

Extended oestrogen-progestin contraceptive regimens: towards a contraception without menses

Revue médicale de Liège, 2006-01, Vol.61 (1), p.23

2006

Volltextzugriff (PDF)

Hemostasis profile in women taking low-dose oral contraceptives

AM. J. OBSTET. GYNECOL. Vol. 163, no. 1. 1990, 1990-07, Vol.163 (1), p.420-423

1990

Volltextzugriff (PDF)

Ulipristal acetate: an emergency contraception extended to 5 days using a progesterone receptor modulator (Ellaone)

Revue médicale de Liège, 2010-12, Vol.65 (12), p.700

2010

Volltextzugriff (PDF)

Therapeutic progress in gynecology: organic diseases

Revue médicale de Liège, 2007-05, Vol.62 (5-6), p.414

2007

Volltextzugriff (PDF)

Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy

Revue médicale de Liège, 2011-04, Vol.66 (4), p.209

2011

Volltextzugriff (PDF)

Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease

American journal of obstetrics and gynecology, 1990-07, Vol.163 (1), p.334-343

1990

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(103)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Französisch
(123)
Englisch
(114)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(165)
Female
(160)
Science & Technology
(67)
Adult
(63)
Life Sciences & Biomedicine
(52)
Pregnancy
(44)
Middle Aged
(41)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Obstetrics & Gynecology
(29)
Population
(22)
Adolescent
(19)
Human Health Sciences
(19)
Sciences De La Santé Humaine
(19)
Gynecology. Andrology. Obstetrics
(16)
Menopause
(16)
Aged
(15)
Radioimmunoassay
(15)
Risk Factors
(13)
Contraceptives, Oral, Combined - Adverse Effects
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women

Low thrombin generation in postmenopausal women using estetrol

Effect of different contraceptive methods on the oxidative stress status in women aged 40–48 years from the ELAN study in the province of Liège, Belgium

Exploring the Interest in and the Usage of the Internet Among Patients Eligible for Osteoporosis Screening

Breast cancer and serum organochlorine residues

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

(068) Low Drug-Drug interaction risk of Estetrol (E4), a Promising New Estrogen for the Treatment of Menopausal Symptoms

ESTETROL/DROSPIRENONE SAFETY IN A CARDIOVASCULAR RISK POPULATION

Skin climacteric aging and hormone replacement therapy

OC 35.3 Correlation between ETP-Based APC Resistance and the Relative Risk of Venous Thromboembolism in Women Using Combined Oral Contraceptives

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

The benefits of estetrol addition to drospirenone for contraception

Relationship between bone mass density and tensile strength of the skin in women

Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects

Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data

Prévention des troubles coronaires par le traitement hormonal précoce à la ménopause : une idée qui s’impose à nouveau

Risks, benefits and costs of hormone replacement therapy in menopause

Extended oestrogen-progestin contraceptive regimens: towards a contraception without menses

Hemostasis profile in women taking low-dose oral contraceptives

Ulipristal acetate: an emergency contraception extended to 5 days using a progesterone receptor modulator (Ellaone)

Therapeutic progress in gynecology: organic diseases

Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy

Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease

Suchergebnisse filtern